SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 23.72
(0.08%)
EUR 23.72
(0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 898.6 Million | 821.14 Million | 648.66 Million | 584.22 Million |
| Cost of Revenue | 582.11 Million | 524.71 Million | 422.49 Million | 388.22 Million |
| Gross Profit | 316.48 Million | 296.42 Million | 226.16 Million | 196 Million |
| Operating Expenses | 124.1 Million | 127.74 Million | 110.92 Million | 104.39 Million |
| Selling, General and Administrative Expenses | 122.08 Million | 110.21 Million | 92.01 Million | 89.22 Million |
| Research and Development Expenses | 26.82 Million | 23.52 Million | 22.28 Million | 23.58 Million |
| Other Expenses | -24.8 Million | 210.99 Thousand | -1.42 Million | -612 Thousand |
| Cost and Expenses | 706.21 Million | 652.45 Million | 533.41 Million | 492.62 Million |
| Operating Income | 192.38 Million | 164.37 Million | 127.65 Million | 98.21 Million |
| Interest Expense | 7.25 Million | 2.68 Million | 1.67 Million | 1.92 Million |
| Income Tax Expense | 33.86 Million | 32.44 Million | 22.11 Million | 17.66 Million |
| Earnings before Tax | 185.8 Million | 158.28 Million | 123.28 Million | 95.29 Million |
| Net Income | 151.84 Million | 125.37 Million | 100.75 Million | 77.48 Million |
| Earnings Per Share Basic | 1.01 | 0.83 | 0.67 | 0.51 |
| Earnings Per Share Diluted | 1.01 | 0.83 | 0.67 | 0.51 |
| Weighted Average Shares Outstanding | 150.61 Million | 150.61 Million | 150.61 Million | 150.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 150.61 Million | 150.61 Million | 150.61 Million | 150.61 Million |
| Gross Margin | 0.35 | 0.36 | 0.35 | 0.34 |
| EBIT Margin | 0.25 | 0.28 | 0.25 | 0.22 |
| Profit Margin | 0.17 | 0.15 | 0.16 | 0.13 |
| EBITDA | 227.64 Million | 203.08 Million | 147.47 Million | 125.21 Million |
| Earnings Before Tax Margin | 0.21 | 0.20 | 0.20 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 254 Million | 234.2 Million | 232 Million | 228.51 Million | 898.6 Million | 221.35 Million |
| Cost of Revenue | 166.5 Million | 155.12 Million | 148.5 Million | 154.21 Million | 582.11 Million | 147.27 Million |
| Gross Profit | 87.49 Million | 79.07 Million | 83.49 Million | 74.29 Million | 316.48 Million | 74.07 Million |
| Operating Expenses | 196 Million | 38.3 Million | 174 Million | 47.92 Million | 145.56 Million | 24.1 Million |
| Selling, General and Administrative Expenses | 31.6 Million | 31.27 Million | 31.49 Million | 30.9 Million | - | 30.55 Million |
| Research and Development Expenses | 5.71 Million | 6.85 Million | 6.27 Million | 8.04 Million | - | 6.58 Million |
| Other Expenses | -196 Million | - | -174 Million | - | -707 Million | - |
| Cost and Expenses | 196 Million | 193.43 Million | 174 Million | 202.14 Million | 727.67 Million | 171.38 Million |
| Operating Income | 58 Million | 28.47 Million | 58 Million | 37.78 Million | 192.38 Million | 42.12 Million |
| Interest Expense | 3.66 Million | 2.9 Million | 2.55 Million | 2.41 Million | 7.25 Million | 1.98 Million |
| Income Tax Expense | 9.48 Million | 1.19 Million | 11.13 Million | 1.54 Million | 33.86 Million | 9.21 Million |
| Earnings before Tax | 55.92 Million | 26.39 Million | 55.64 Million | 36.25 Million | 185.8 Million | 39.77 Million |
| Net Income | 46.26 Million | 25.03 Million | 44.41 Million | 34.69 Million | 151.84 Million | 30.48 Million |
| Earnings Per Share Basic | 0.31 | 0.17 | 0.29 | 0.23 | - | 0.20 |
| Earnings Per Share Diluted | 0.31 | 0.17 | 0.29 | 0.23 | - | 0.20 |
| Weighted Average Shares Outstanding | 150.61 Million | 150.61 Million | 153.14 Million | 150.61 Million | 150.61 Million | 150.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 150.61 Million | 150.61 Million | 153.14 Million | 150.61 Million | 150.61 Million | 150.61 Million |
| Gross Margin | 0.34 | 0.34 | 0.36 | 0.33 | 0.35 | 0.33 |
| EBIT Margin | 0.30 | 0.19 | 0.31 | 0.25 | - | 0.25 |
| Profit Margin | 0.18 | 0.11 | 0.19 | 0.15 | 0.17 | 0.14 |
| EBITDA | 76.08 Million | 45.14 Million | 72.63 Million | 57.71 Million | - | 55.15 Million |
| Earnings Before Tax Margin | 0.23 | 0.12 | 0.25 | 0.17 | 0.21 | 0.19 |
TCBS
NVAAF
VC
PAE
ALC
MAPSW